Search Results - "Rotstein, C."

Refine Results
  1. 1

    The Role of Antiviral Prophylaxis for the Prevention of Epstein–Barr Virus–Associated Posttransplant Lymphoproliferative Disease in Solid Organ Transplant Recipients: A Systematic Review by AlDabbagh, M. A., Gitman, M. R., Kumar, D., Humar, A., Rotstein, C., Husain, S.

    Published in American journal of transplantation (01-03-2017)
    “…The role of antiviral prophylaxis for the prevention of posttransplant lymphoproliferative disease (PTLD) remains controversial for solid organ transplantation…”
    Get full text
    Journal Article
  2. 2

    Post renal transplantation Kaposi's sarcoma: a review of its epidemiology, pathogenesis, diagnosis, clinical aspects, and therapy by Hosseini-Moghaddam, S.M., Soleimanirahbar, A., Mazzulli, T., Rotstein, C., Husain, S.

    Published in Transplant infectious disease (01-08-2012)
    “…: Background Kaposi's sarcoma (KS) is a vascular malignancy primarily involving the skin. This neoplasm occurs commonly in acquired immunodeficiency syndrome…”
    Get full text
    Journal Article
  3. 3

    Risk Factors for Voriconazole Hepatotoxicity at 12 Weeks in Lung Transplant Recipients by Luong, M‐L., Hosseini‐Moghaddam, S. M., Singer, L. G., Chaparro, C., Azad, S., Lazar, N., Boutros, P. C., Keshavjee, S., Rotstein, C., Husain, S.

    Published in American journal of transplantation (01-07-2012)
    “…Voriconazole is commonly used for prophylaxis and treatment of invasive aspergillosis in lung transplant recipients. However, the use of voriconazole may at…”
    Get full text
    Journal Article
  4. 4

    Evaluation of a Routine Screening Program with Tuberculin Skin Testing on Rates of Detection of Latent Tuberculosis Infection and Prevention of Active Tuberculosis in Patients with Multiple Myeloma at a Canadian Cancer Centre by Gitman, M., Vu, J., Nguyen, T., Chen, C., Rotstein, C.

    Published in Current oncology (Toronto) (01-06-2020)
    “…Background: Chemotherapy-induced T cell dysfunction, resulting from treatment of multiple myeloma (MM), enhances the risk for reactivation of latent…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Successful treatment of gastrointestinal mucormycosis in an adult with acute leukemia: case report and literature review by Alghamdi, A, Lutynski, A, Minden, M, Rotstein, C

    Published in Current oncology (Toronto) (01-02-2017)
    “…Mucormycosis has emerged as an important cause of invasive fungal infection in patients with hematologic malignancies. Gastrointestinal mucormycosis is an…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    Rate of cyp51A mutation in Aspergillus fumigatus among lung transplant recipients with targeted prophylaxis by Shalhoub, S, Luong, M-L, Howard, S J, Richardson, S, Singer, L G, Chaparro, C, Keshavjee, S, Akinlolu, Y, Rotstein, C, Mazzulli, T, Husain, S

    Published in Journal of antimicrobial chemotherapy (01-04-2015)
    “…The most common mechanism of azole (itraconazole and voriconazole) resistance in Aspergillus fumigatus is a mutation at the cyp51A locus. The aim of our study…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    Anti-Fungal Prophylaxis in Lung Transplant Recipients (LTRs): A Meta-Analysis of Cohort Studies by Bhaskaran, A, Mumtaz, K, Singer, L.G, Rotstein, C, Husain, S

    “…Purpose Majority of lung transplant centers have adopted antifungal prophylaxis directed against Aspergillus (Asp) species based on single center cohort…”
    Get full text
    Journal Article
  18. 18

    Does CMV Mismatch Status Modify the Risk of PTLD Due to EBV Mismatch Status in Lung and Heart Transplant Recipients? by Luong, M.-L, Kim, J, Rotstein, C, Husain, S

    “…Purpose Epstein-Barr virus (EBV) mismatch is a known risk factor for posttransplant lymphoproliferative disorders (PTLD) in lung and heart transplant…”
    Get full text
    Journal Article
  19. 19

    Hepatitis C core Ag and its clinical applicability: Potential advantages and disadvantages for diagnosis and follow-up? by Hosseini-Moghaddam, SM, Iran-Pour, E., Rotstein, C., Husain, S., Lilly, L., Renner, E., Mazzulli, T.

    Published in Reviews in medical virology (01-05-2012)
    “…SUMMARY Chronic hepatitis C virus (HCV) infection which is often a silent disease has resulted in a global epidemic. The diagnosis of hepatitis C virus often…”
    Get full text
    Journal Article
  20. 20

    A comparative study of the use of selective digestive decontamination prophylaxis in living-donor liver transplant recipients by Katchman, E., Marquez, M., Bazerbachi, F., Grant, D., Cattral, M., Low, C.Y., Renner, E., Humar, A., Selzner, M., Ghanekar, A., Rotstein, C., Husain, S.

    Published in Transplant infectious disease (01-08-2014)
    “…Introduction Bacterial infections are major causes of early morbidity and mortality after liver transplantation. Selective digestive decontamination (SDD) can…”
    Get full text
    Journal Article